Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- us
- equities
- Food for Thoughts
- macro
- sp500
- Bonds
- Asia
- bitcoin
- Central banks
- markets
- technical analysis
- investing
- inflation
- europe
- Crypto
- interest-rates
- Commodities
- geopolitics
- performance
- gold
- ETF
- nvidia
- tech
- AI
- earnings
- Forex
- Real Estate
- oil
- bank
- FederalReserve
- Volatility
- apple
- nasdaq
- emerging-markets
- magnificent-7
- Alternatives
- energy
- switzerland
- trading
- tesla
- sentiment
- Money Market
- russia
- France
- UK
- assetmanagement
- china
- ESG
- Middle East
- amazon
- ethereum
- microsoft
- meta
- bankruptcy
- Industrial-production
- Turkey
- Healthcare
- Global Markets Outlook
- recession
- africa
- brics
- Market Outlook
- Yields
- Focus
- shipping
- wages
$NVDA NVIDIA Q2 FY24 in one chart by App Economy Insight
Nvidia shares climbed 8% in extended trading on Wednesday after the chipmaker beat estimates for the second quarter and issued optimistic guidance for the current period. Nvidia said it expects third-quarter revenue of about $16 billion, higher than $12.61 billion forecast by Refinitiv. Nvidia’s guidance suggests sales will grow 170% on an annual basis in the current quarter. Source: CNBC, App Economy Insight
The Nvidia share shows very well that analysts usually lag behind the share price with their price targets
Source: HolgerZ, Bloomberg
Investing requires patience. Over the past 15 years, investors in these stocks navigated significant drawdowns before reaping substantial gains
The same principle might apply to bitcoin and some cryptocurrencies as well. Source: ycharts, Beth Kindig
Eli Lilly stock hit a new record high yesterday as the company continues to record a surge in sales for its buzzy diabetes drug Mounjaro
Sales of Mounjaro, which has also gained popularity for weight loss, came in at $979.7 million for the second quarter, up from $16 million a year earlier when it was introduced (2Q results were publichsed 2 weeks ago). That helped the drug company post higher-than-expected sales for the second quarter. Novo Nordisk is also surfing on the strong demand for a similar weight loss blockbuster
Bespokeinvest posted: "Here's one way to think about investing in equities and "buy and hold."
Casinos make money by making sure bettors eventually lose more often than they win. The stock market is the opposite. The longer you play, the better your odds. Historically, the odds of the S&P 500 being up over any one-month time frame have been 62.6%. Over a year, the odds of being up jump to 74.6%, and over eight years, they jump to 97%. Since 1928, all 16+ year time frames have seen positive returns. Check out this chart Bespokeinvest created to help people visualize this data a couple of years ago (updated through July 2023):
US equities: absolute & relative valuations offer a different perspective
•On the positive side, market (absolute) valuations have improved as stock prices have dipped and earnings have held up •On the negative side, the rise in bond yields imply a lower Equity Risk Premium (ERP), now at 39bps (19-year low), i.e equities are more expensive vs. bonds than at the start of the Summer... Source: Edward Jones, BofA
Investing with intelligence
Our latest research, commentary and market outlooks